epilepsy market

Global Epilepsy Market Research Report: By Condition (Epilepsy Drug Resistant/Intractable Epilepsy, Others), By Diagnosis & Treatment (Diagnosis & Treatment), By End-use (Hospitals, Clinics, Ambulatory Surgical Centres, Diagnostic Centres, Others) - Forecast till 2028

  • Published Date: 2022-12-26
  • Report ID: 138106
  • Pages: 200
  • Format: prudent report format

Report Overview

The global epilepsy market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 8.95% during the forecast period.

Epilepsy is a neurological disorder which usually causes seizers, sensation and other problems as it causes abnormalities in the brain. Seizures are the main symptoms of the epilepsy which usually causes disturbance in persons mental, sensory and motor functions. Tumour, head injuries, stroke, alcohol withdrawal, birth injuries among others are some of the common reason for the epilepsy.

Each year 150,000 Americans are identified with central nervous system disorder and every 1 in 26 U.S. people are diagnosed with this disease. After migraine, stroke and Alzheimer, Epilepsy is the fourth most common neurological disease.



Market Drivers

Increasing epilepsy cases among aging population is driving the market growth. Rising neurological diseases among population will also propel the growth of the market, and increasing brain injuries cases due to road accidents will also drive the growth of this market. Growing funding for R&D of epilepsy is also contributing as a factor for the market growth.

 




  1. Global Epilepsy Market Overview.........................................................

    1. Market Size



  2. Market Growth Drivers...

    1. Rising Prevalence Of Epilepsy Amongst The Geriatric Population

    2. Increasing Cases Of Brain Injuries Due To Road Accidents

    3. Rising Neurological Disorders



  3. Epilepsy Market Segmentation.............................................................

    1. By Condition

      1. Epilepsy Drug Resistant/ Intractable Epilepsy

      2. Others



    2. By Diagnosis and Treatment

      1. Diagnosis and Treatment



    3. By End Use

      1. Hospitals

      2. II. Clinics

      3. Ambulatory Surgical Centres

      4. Diagnostic Centres

      5. Others



    4. By Geography

      1. America Market Analysis

      2. Europe Market Analysis

      3. Asia-Pacific Market Analysis

      4. Middle-East and Africa Market Analysis





  4. Epilepsy Major Market Share by Revenue....

    1. Key Findings

    2. Market Analysis, Insights and Forecast



  5. Competitive Landscape......

    1. Major Players

    2. Products in Pipeline



  6. Key Company Profiles....

    1. GSK Company overview, Product & Services, Strategies & Financials

    2. Eisai Company overview, Product & Services, Strategies & Financials

    3. LivaNova Company, Product & Services, Strategies & Financials



  7. Healthcare Policies and Regulatory Landscape..

    1. Policy changes and Reimbursement scenario



  8. Factors Driving Future Growth..

    1. Key Industry Developments



  9. Potential Growth Opportunities.

    1. Future Opportunities



  10. Conclusion


CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.